Cargando…

First person – Xiao-Zhi Cheng

First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping early-career researchers promote themselves alongside their papers. Xiao-Zhi Cheng is first author on ‘ Intercellular transfer of P-glycoprotein mediates the formation of stable...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550085/
http://dx.doi.org/10.1242/bio.043752
_version_ 1783424126424186880
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping early-career researchers promote themselves alongside their papers. Xiao-Zhi Cheng is first author on ‘ Intercellular transfer of P-glycoprotein mediates the formation of stable multidrug resistance in human bladder cancer BIU-87 cells’, published in BiO. Xiao-Zhi conducted the research described in this article while a Master’s student in Professor Hui-Liang Zhou’s lab at Fujian Medical University, People's Republic of China. He is now an attending physician in the lab of Hui-liang Zhou at Huanggang Central Hospital, China, investigating the mechanism of multidrug resistance formation and the role of P-glycoprotein within it.
format Online
Article
Text
id pubmed-6550085
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-65500852019-06-07 First person – Xiao-Zhi Cheng Biol Open First Person First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping early-career researchers promote themselves alongside their papers. Xiao-Zhi Cheng is first author on ‘ Intercellular transfer of P-glycoprotein mediates the formation of stable multidrug resistance in human bladder cancer BIU-87 cells’, published in BiO. Xiao-Zhi conducted the research described in this article while a Master’s student in Professor Hui-Liang Zhou’s lab at Fujian Medical University, People's Republic of China. He is now an attending physician in the lab of Hui-liang Zhou at Huanggang Central Hospital, China, investigating the mechanism of multidrug resistance formation and the role of P-glycoprotein within it. The Company of Biologists Ltd 2019-05-15 /pmc/articles/PMC6550085/ http://dx.doi.org/10.1242/bio.043752 Text en © 2019. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/4.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – Xiao-Zhi Cheng
title First person – Xiao-Zhi Cheng
title_full First person – Xiao-Zhi Cheng
title_fullStr First person – Xiao-Zhi Cheng
title_full_unstemmed First person – Xiao-Zhi Cheng
title_short First person – Xiao-Zhi Cheng
title_sort first person – xiao-zhi cheng
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550085/
http://dx.doi.org/10.1242/bio.043752